Literature DB >> 9277645

Effects of autoantibodies on the course of pregnancy and fetal growth.

T Iijima1, H Tada, Y Hidaka, N Mitsuda, Y Murata, N Amino.   

Abstract

OBJECTIVE: To assess the effects of autoantibodies on the course of pregnancy and fetal growth.
METHODS: One thousand one hundred seventy-nine healthy women with singleton gestations were screened in early pregnancy for seven kinds of autoantibodies: antithyroid microsomal antibody, antithyroglobulin antibody, two kinds of rheumatoid factor, antinuclear antibody, anti-DNA antibody, and antimitochondrial antibody.
RESULTS: In 228 cases (19.3%), at least one autoantibody was found; however, overlap of autoantibodies in the same individual was unexpectedly rare, and only two cases were positive for as many as four autoantibodies. A significantly higher rate of spontaneous abortion was observed in antibody-positive subjects, especially those with antithyroid microsomal (10.4%) or antinuclear antibodies (16.0%), compared with all antibody-negative subjects (5.5%). There were no significant differences in any outcome assessed among subjects positive for antithyroglobulin antibody, anti-DNA antibody, or antimitochondrial antibody compared with all antibody-negative subjects. None of the seven autoantibodies affected the rates of preterm delivery, stillbirth, pregnancy-induced hypertension, malformation, or gender ratio.
CONCLUSION: Antithyroid microsomal antibody and antinuclear antibody are the only autoantibodies that increase the abortion rate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9277645     DOI: 10.1016/s0029-7844(97)00283-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  27 in total

Review 1.  The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 2.  Thyroid autoimmunity and pre-term delivery: brief review and meta-analysis.

Authors:  R Negro
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

3.  Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.

Authors:  Andrea Reh; Sonal Chaudhry; Felicia Mendelsohn; Shelly Im; Linda Rolnitzky; Alana Amarosa; Mortimer Levitz; Suman Srinivasa; Lewis Krey; Alan S Berkeley; James A Grifo; Ann Danoff
Journal:  Fertil Steril       Date:  2010-11-03       Impact factor: 7.329

4.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

5.  Autoimmunity: thyroid autoantibodies and pregnancy risk.

Authors:  Erik K Alexander
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

6.  The Effect of Anti-Thyroid Peroxidase Antibodies on Pregnancy Outcomes in Euthyroid Women.

Authors:  Monika Meena; Seema Chopra; Vanita Jain; Neelam Aggarwal
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Thyroid physiology and common diseases in pregnancy: review of literature.

Authors:  Pietro Cignini; Ester Valentina Cafà; Claudio Giorlandino; Stella Capriglione; Anna Spata; Nella Dugo
Journal:  J Prenat Med       Date:  2012-10

Review 8.  Thyroid function in pregnancy.

Authors:  Angela M Leung
Journal:  J Trace Elem Med Biol       Date:  2012-06-02       Impact factor: 3.849

9.  Prediction of postpartum onset of rheumatoid arthritis.

Authors:  T Iijima; H Tada; Y Hidaka; A Yagoro; N Mitsuda; T Kanzaki; Y Murata; N Amino
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

10.  Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies.

Authors:  Reyhane Rahnama; Ahmad-Reza Mahmoudi; Somayeh Kazemnejad; Mansour Salehi; Ataollah Ghahiri; Haleh Soltanghoraee; Sedigheh Vafaei; Abbas Rezaei; Amir Hassan Zarnani
Journal:  Clin Exp Med       Date:  2020-09-26       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.